![[SEBASTIAN KAULITZKI] - STOCK.ADOBE.COM](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3fbe7b21eef28f23798900792090beea0407b955-950x1030.png?w=350&fit=crop&auto=format)
Determining treatment options for patients with locally advanced rectal cancer after the PROSPECT trial data readout adds an important level to the decision-making process.
Manju George, PhD
Advertisement
Articles by Manju George, PhD
Advertisement
Latest Updated Articles
![[SEBASTIAN KAULITZKI] - STOCK.ADOBE.COM](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3fbe7b21eef28f23798900792090beea0407b955-950x1030.png?w=300&fit=crop&auto=format)
Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT TrialPublished: May 15th 2024 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
